GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NextGen Biomed Ltd (XTAE:NXGN) » Definitions » FCF Yield %

NextGen Biomed (XTAE:NXGN) FCF Yield % : -65.63 (As of Apr. 11, 2025)


View and export this data going back to 2000. Start your Free Trial

What is NextGen Biomed FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, NextGen Biomed's Trailing 12-Month Free Cash Flow is ₪-3.05 Mil, and Market Cap is ₪4.64 Mil. Therefore, NextGen Biomed's FCF Yield % for today is -65.63%.

The historical rank and industry rank for NextGen Biomed's FCF Yield % or its related term are showing as below:

XTAE:NXGN' s FCF Yield % Range Over the Past 10 Years
Min: -68.08   Med: 0   Max: 0
Current: -65.63


XTAE:NXGN's FCF Yield % is ranked worse than
90.23% of 870 companies
in the Medical Devices & Instruments industry
Industry Median: -2.065 vs XTAE:NXGN: -65.63

NextGen Biomed's FCF Margin % for the quarter that ended in Jun. 2024 was 0.00%.


NextGen Biomed FCF Yield % Historical Data

The historical data trend for NextGen Biomed's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NextGen Biomed FCF Yield % Chart

NextGen Biomed Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -14.83 -2.94 -5.71 -10.13 -48.04

NextGen Biomed Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.02 -10.65 -22.49 -44.10 -27.29

Competitive Comparison of NextGen Biomed's FCF Yield %

For the Medical Instruments & Supplies subindustry, NextGen Biomed's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NextGen Biomed's FCF Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NextGen Biomed's FCF Yield % distribution charts can be found below:

* The bar in red indicates where NextGen Biomed's FCF Yield % falls into.


;
;

NextGen Biomed FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

NextGen Biomed's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-4.438 / 9.238536
=-48.04%

NextGen Biomed's annualized FCF Yield % for the quarter that ended in Jun. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-1.009 * 2 / 7.393734
=-27.29%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NextGen Biomed FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


NextGen Biomed FCF Yield % Related Terms

Thank you for viewing the detailed overview of NextGen Biomed's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


NextGen Biomed Business Description

Traded in Other Exchanges
N/A
Address
Azrieli Center, Round Tower 22nd Floor, Tel Aviv, ISR, 6701101
NextGen Biomed Ltd is pharmaceutical company. It manufactures medical instruments. Its products include pain-free auto-injectors, lancet devices and personal use pain alleviators. It develops and markets medical equipments. Its product line include DPS-101, which is used for treatment for psoriasis. Its other product line include DPS-101 phase II/III is in clinical trial.